Farhadian Joshua A, Terushkin Vitaly, Meehan Shane A, Kornreich Craig
Ronald O. Perelman Department of Dermatology, NYU School of Medicine, NYU Langone Medical Center.
Dermatol Online J. 2016 Dec 15;22(12):13030/qt9gz970jm.
Anaplastic large-cell lymphomas (ALCLs) are agroup of CD30-positive non-Hodgkin lymphomasthat are linked by common morphologic andimmunophenotypic features but have varyingclinical and genetic characteristics. The World HealthOrganization classification currently recognizes threesubtypes of ALCL: systemic anaplastic lymphomakinase-positive ALCL, systemic anaplastic lymphomakinase-negative (ALK-) ALCL, and primary cutaneousALCL. Here we present a 42-year-old man with ahistory of systemic ALK- ALCL, who was in remissionfor six months before relapsing with skin-limitedanaplastic large-cell lymphoma.
间变性大细胞淋巴瘤(ALCL)是一组CD30阳性的非霍奇金淋巴瘤,它们具有共同的形态学和免疫表型特征,但临床和基因特征各不相同。世界卫生组织分类目前认可ALCL的三种亚型:系统性间变性淋巴瘤激酶阳性ALCL、系统性间变性淋巴瘤激酶阴性(ALK-)ALCL和原发性皮肤ALCL。在此,我们报告一名42岁有系统性ALK-ALCL病史的男性,他在缓解六个月后复发为皮肤局限性间变性大细胞淋巴瘤。